Nuclear factor-kappa B (NF-κB) signaling lies at the epicenter of immune regulation in cancer, functioning as a molecular switchboard that integrates external inflammatory cues with internal transcriptional responses (1, 2). The gene discussed is NFKB1; the disease is cancer.